GSA Capital Partners LLP Invests $690,000 in UFP Technologies, Inc. (NASDAQ:UFPT)

Key Points

• GSA Capital Partners LLP has invested approximately $690,000 in UFP Technologies, purchasing 3,423 shares in the industrial products company.
• UFP Technologies recently reported $2.47 earnings per share for the quarter, exceeding analysts' expectations of $2.05, alongside a revenue of $148.15 million.
• Lake Street Capital has set a $252.00 price target on UFP Technologies and issued a "buy" rating for the stock.

GSA Capital Partners LLP purchased a new position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,423 shares of the industrial products company's stock, valued at approximately $690,000.

A number of other institutional investors have also recently made changes to their positions in UFPT. Johnson Financial Group Inc. bought a new position in UFP Technologies during the fourth quarter valued at approximately $42,000. Lazard Asset Management LLC purchased a new stake in shares of UFP Technologies during the 4th quarter worth approximately $84,000. Park Square Financial Group LLC bought a new position in shares of UFP Technologies during the 4th quarter valued at approximately $107,000. Canada Pension Plan Investment Board grew its holdings in shares of UFP Technologies by 25.0% in the fourth quarter. Canada Pension Plan Investment Board now owns 500 shares of the industrial products company's stock valued at $122,000 after purchasing an additional 100 shares in the last quarter. Finally, Dakota Wealth Management purchased a new position in shares of UFP Technologies in the first quarter valued at $204,000. Hedge funds and other institutional investors own 87.28% of the company's stock.

Analyst Ratings Changes

Separately, Lake Street Capital set a $252.00 price target on shares of UFP Technologies and gave the company a "buy" rating in a research note on Wednesday, May 7th.

Insider Buying and Selling at UFP Technologies

In related news, SVP Christopher P. Litterio sold 1,473 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $220.12, for a total transaction of $324,236.76. Following the completion of the sale, the senior vice president directly owned 12,585 shares of the company's stock, valued at approximately $2,770,210.20. This trade represents a 10.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.40% of the company's stock.

UFP Technologies Trading Down 8.8%

UFPT stock traded down $21.30 during midday trading on Wednesday, reaching $219.45. 66,122 shares of the company traded hands, compared to its average volume of 136,394. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 25.43 and a beta of 1.14. UFP Technologies, Inc. has a 52-week low of $178.26 and a 52-week high of $366.41. The business has a 50 day moving average of $238.69 and a 200-day moving average of $233.07. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.45 and a current ratio of 2.58.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The industrial products company reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.25 by $0.25. The company had revenue of $151.18 million for the quarter, compared to analyst estimates of $151.55 million. UFP Technologies had a return on equity of 22.19% and a net margin of 11.40%. UFP Technologies's quarterly revenue was up 37.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.86 EPS.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.